These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8921832

  • 1. Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat.
    Torsello A, Grilli R, Luoni M, Guidi M, Ghigo MC, Wehrenberg WB, Deghenghi R, Müller EE, Locatelli V.
    Eur J Endocrinol; 1996 Oct; 135(4):481-8. PubMed ID: 8921832
    [Abstract] [Full Text] [Related]

  • 2. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
    Torsello A, Luoni M, Grilli R, Guidi M, Wehrenberg WB, Deghenghi R, Müller EE, Locatelli V.
    Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
    [Abstract] [Full Text] [Related]

  • 3. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
    Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B.
    Regul Pept; 1997 May 14; 70(1):49-54. PubMed ID: 9250581
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE, Marazzi N, Cella SG, Cattaneo L, Müller EE.
    J Endocrinol; 1998 Feb 14; 156(2):341-8. PubMed ID: 9518881
    [Abstract] [Full Text] [Related]

  • 5. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D, Popovic V, Kendereski A, Peino R, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1996 Nov 14; 45(5):543-51. PubMed ID: 8977750
    [Abstract] [Full Text] [Related]

  • 6. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1997 May 14; 46(5):539-43. PubMed ID: 9231048
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
    Locatelli V, Grilli R, Torsello A, Cella SG, Wehrenberg WB, Müller EE.
    Pediatr Res; 1994 Aug 14; 36(2):169-74. PubMed ID: 7970930
    [Abstract] [Full Text] [Related]

  • 8. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone.
    Conley LK, Brogan RS, Giustina A, Wehrenberg WB.
    Pituitary; 2000 May 14; 2(4):253-60. PubMed ID: 11081146
    [Abstract] [Full Text] [Related]

  • 9. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1994 Nov 14; 79(5):1440-3. PubMed ID: 7962341
    [Abstract] [Full Text] [Related]

  • 10. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E, Di Vito L, Ramunni J, Gianotti L, Giordano R, Deghenghi R, Camanni F, Ghigo E.
    Clin Endocrinol (Oxf); 1997 Oct 14; 47(4):495-500. PubMed ID: 9404449
    [Abstract] [Full Text] [Related]

  • 11. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB.
    J Neuroendocrinol; 1999 Jul 14; 11(7):521-8. PubMed ID: 10444309
    [Abstract] [Full Text] [Related]

  • 12. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF, Hindmarsh PC, Brook CG.
    Clin Endocrinol (Oxf); 1997 Nov 14; 47(5):537-47. PubMed ID: 9425393
    [Abstract] [Full Text] [Related]

  • 13. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
    Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    Metabolism; 1995 Jan 14; 44(1):134-8. PubMed ID: 7854159
    [Abstract] [Full Text] [Related]

  • 14. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
    Bresciani E, Nass R, Torsello A, Gaylinn B, Avallone R, Locatelli V, Thorner MO, Müller EE.
    Neuroendocrinology; 2004 Jan 14; 80(1):52-9. PubMed ID: 15361691
    [Abstract] [Full Text] [Related]

  • 15. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R.
    Clin Endocrinol (Oxf); 1996 Sep 14; 45(3):341-51. PubMed ID: 8949573
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
    Giustina A, Desenzani P, Perini P, Deghenghi R, Bugari G, Wehrenberg WB, Giustina G.
    Endocr Res; 1996 May 14; 22(2):159-74. PubMed ID: 8799695
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
    Conley LK, Teik JA, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V, Wehrenberg WB.
    Neuroendocrinology; 1995 Jan 14; 61(1):44-50. PubMed ID: 7731497
    [Abstract] [Full Text] [Related]

  • 18. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?
    Roh SG, Chen C, Choi KC, Shrestha Y, Sasaki S.
    Endocrinology; 2002 May 14; 143(5):1964-7. PubMed ID: 11956179
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
    Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F.
    J Clin Endocrinol Metab; 1994 Mar 14; 78(3):693-8. PubMed ID: 8126144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.